Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy
Sanofi has announced the discontinuation of its Phase 3 MOBILIZE study evaluating…
Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors
Harbour BioMed has announced that China’s National Medical Products Administration (NMPA) has…
GSK completes acquisition of 35Pharma Inc.
GSK plc has completed the acquisition of 35Pharma Inc., adding HS235, a…
GSK to Acquire RAPT Therapeutics, Advancing Long-Acting IgE Therapy for Food Allergy Patients
GSK has agreed to acquire RAPT Therapeutics, adding a long-acting anti-IgE therapy…
Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk
Novo Nordisk announced that Maziar Mike Doustdar has been appointed as president…
AstraZeneca Reveals New Research on Respiratory & Immune Diseases
May 2024- AstraZeneca will showcase new clinical and real-world data across its…
